Evidence map›Paper›PMID 20103721›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2010

zeta-Crystallin is a bcl-2 mRNA binding protein involved in bcl-2 overexpression in T-cell acute lymphocytic leukemia.

Andrea Lapucci, Matteo Lulli, Amedeo Amedei, Laura Papucci, Ewa Witort, Federico Di Gesualdo, Francesco Bertolini, Gary Brewer, Angelo Nicolin, Annamaria Bevilacqua and 4 more

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. BCL-2 and BCL-xL in Cancer: Regulation, Function, and Therapeutic Targeting.International journal of molecular sciences · 2026
    Review
  3. Article
  4. Article
  5. Investigating the Prevalence of RNA-Binding Metabolic Enzymes inInternational journal of molecular sciences · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Zeta-crystallin: a moonlighting player in cancer.Cellular and molecular life sciences : CMLS · 2020
    Review
  10. Identification ofNeurology. Genetics · 2019
    Article
  11. Post-Transcriptional Regulation of Anti-Apoptotic BCL2 Family Members.International journal of molecular sciences · 2018
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Andrea LapucciDepartment of Experimental Pathology and Oncology, University of Florence, Florence, Italy.
Matteo Lulli
Amedeo Amedei
Laura Papucci
Ewa Witort
Federico Di Gesualdo
Francesco Bertolini
Gary Brewer
Angelo Nicolin
Annamaria Bevilacqua
Nicola Schiavone
Dominique Morello
Martino Donnini
Sergio Capaccioli
University of Florence · ITUniversity of Milan · ITEuropean Institute of Oncology · IT

Funding

POST TRANSCRIPTIONAL REGULATION--ONCOGENE MESSENGER RNAR01CA052443 · NCI · WAKE FOREST UNIVERSITY · PI BREWER, GARY A. · 1990 to 2012
$4.3M
NCI NIH HHS R01 CA052443
6 · The paper itself

Abstract

The human antiapoptotic bcl-2 gene has been discovered in t(14;18) B-cell leukemias/lymphomas because of its overexpression caused at a transcriptional control level by the bcl-2/IgH fusion gene. We were the first to disclose the post-transcriptional control of bcl-2 expression mediated by interactions of an adenine + uracil (AU)-rich element (ARE) in the 3'-UTR of bcl-2 mRNA with AU-binding proteins (AUBPs). Here, we identify and characterize zeta-crystallin as a new bcl-2 AUBP, whose silencing or overexpression has impact on bcl-2 mRNA stability. An increased Bcl-2 level observed in normal phytohemagglutinin (PHA)-activated T lymphocytes, acute lymphatic leukemia (ALL) T-cell lines, and T cells of patients with leukemia in comparison with normal non-PHA-activated T lymphocytes was concomitant with an increase in zeta-crystallin level. The specific association of zeta-crystallin with the bcl-2 ARE was significantly enhanced in T cells of patients with ALL, which accounts for the higher stability of bcl-2 mRNA and suggests a possible contribution of zeta-crystallin to bcl-2 overexpression occurring in this leukemia.

Indexed as

3' Untranslated RegionsBlotting, WesternCytoplasmFemaleGene Expression RegulationHumansImmunoprecipitationMaleMiddle AgedPhytohemagglutininsPrecursor T-Cell Lymphoblastic Leukemia-LymphomaProto-Oncogene Proteins c-bcl-2Reverse Transcriptase Polymerase Chain ReactionRNA, MessengerRNA, Small InterferingSpectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization3' Untranslated RegionsPhytohemagglutininsProto-Oncogene Proteins c-bcl-2RNA, MessengerRNA, Small Interferingzeta-Crystallins

Identifiers

PMID20103721
PMCPMC2874474
OpenAlexW2160951381

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.